Recent Updates
Recently added Catalysts
CYH Neutral Sentiment Score: 45/100

Community Health Systems, Inc. Announces Second Quarter Ended June 30, 2026 Results

Wednesday, July 22, 2026 1 min read
Key Takeaway: Community Health Systems, Inc. reported its financial results for the second quarter of 2026, revealing net operating revenues of $2.825 billion. The company reported a net income of $70 million, translating to $0.51 per diluted share. This marks a significant decrease in net income compared to the previous year's figures.

Market Sentiment Analysis

POSITIVE FACTORS

  • Net operating revenues reached $2.825 billion.
  • The company continues to report financial results.
  • Net income attributable to stockholders was $70 million.

CONCERNS & RISKS

  • Net income decreased significantly from $282 million to $70 million.
  • Earnings per share dropped from $2.09 to $0.51.

Full Press Release Details

FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (NYSE: CYH) (the “Company”) today announced financial and operating results for the three and six months ended June 30, 2026. The following highlights the financial and operating results for the three months ended June 30, 2026. Net operating revenues totaled $2.825 billion. Net income attributable to Community Health Systems, Inc. stockholders was $70 million, or $0.51 per share (diluted), compared to $282 million, or $2.09 per s

Frequently Asked Questions

What were the net operating revenues for Q2 2026?

The net operating revenues for Q2 2026 totaled $2.825 billion.

What was the net income for Community Health Systems in Q2 2026?

The net income attributable to stockholders was $70 million.

How much did earnings per share drop in Q2 2026?

Earnings per share dropped from $2.09 to $0.51.

When did Community Health Systems announce their Q2 results?

The results were announced for the three months ended June 30, 2026.

Tags: CYH Viatris Investor Conferences Healthcare Community Health Systems financial results Q2 2026 net income
Last updated: Jul 22, 2026

Biotech snapshot

Cash runway
$712M liquidity · $99M/mo burn
~4 mo
High dilution risk